Articles

Identifying growth drivers: three simple steps to boost in-line brand …

2nd October 2014

Identifying growth drivers: three simple steps to boost in-line brand performanceDeborah Runge

Marketing managers can use a customised diagnostic and the right metrics to uncover growth drivers which could help boost a brand's performance, says Deborah Runge.What is a growth driver?Finding ways... Read more

Patient perspectives from The Brain Tumour Charity

1st October 2014

Patient perspectives from The Brain Tumour CharityKate Kershaw

Kate Kershaw, head of support and information at The Brain Tumour Charity, talks to pharmaphorum about what patients need as it launches its latest initiative – an online resource featuring... Read more

UK Prix Galien: First therapy for pulmonary fibrosis

1st October 2014

UK Prix Galien: First therapy for pulmonary fibrosisStaff reporter

The final article in our series highlighting some of the shortlisted products in the UK Prix Galien awards focuses on Esbriet, the first drug approved for idiopathic pulmonary fibrosis and... Read more

Collaboration advances research into childhood cancers

30th September 2014

Collaboration advances research into childhood cancersLouise Bellamy

As September is Childhood Cancer Awareness Month in the UK, it is a good time to highlight the work being done in research and clinical trials, review developments to date,... Read more

News

AbbVie assures staff Shire merger to go ahead

1st October 2014

AbbVie assures staff Shire merger to go aheadLinda Banks

Following the tightening of tax regulations in the US to discourage tax inversion mergers with international companies, AbbVie CEO Richard Gonzalez has told employees that the takeover of Shire will... Read more

FDA supports rare disease research with $19m fund

1st October 2014

FDA supports rare disease research with $19m fundAndrew McConaghie

The FDA has awarded $19 million in funding to help accelerate the development of medical device, drug, and biological products for patients with rare diseases.The US regulator has awarded grants... Read more

Regeneron and Sanofi’s dupilumab delivers in phase IIa for sinusitis

30th September 2014

Regeneron and Sanofi’s dupilumab delivers in phase IIa for sinusitisLinda Banks

Regeneron Pharmaceuticals and Sanofi have announced more positive results for their novel drug dupilumab in the allergic inflammatory arena.Their phase IIa proof-of-concept study of dupilumab, which works by blocking IL-4... Read more

Opdivo to be reviewed in Europe for lung cancer

29th September 2014

Opdivo to be reviewed in Europe for lung cancerAndrew McConaghie

Bristol-Myers Squibb has announced that its new immunotherapy treatment nivolumab has been accepted for review by the EMA for non-small cell lung cancer (NSCLC).The EMA has formally accepted the firm's submission, which puts it in pole... Read more

Audio & Video

Live webinar: Is pharma brand marketing …

Kantar Health webinar


While pharma observers speculate on the death of outdated drug discovery and sales models, some critical wounds to... View more

View the conversation - Tweetchat: Manag…

Atlantis Healthcare diabetes Tweetchat


Working in partnership, Atlantis Healthcare and pharmaphorum conducted a Tweetchat focussed on the real world challenges patients face in managing... View more

Patient Opinion Leaders: Andrew Schorr

 

As a cancer survivor and passionate patient advocate, Andrew Schorr typifies the concept of a Patient Opinion Leader (POL). He is a contributor to the... View more

View the recorded webinar - The future o…

WEBINAR COVER smaller


The global pharmaceutical market passes a significant milestone in 2014: reaching one trillion US dollars in total value. IMS Health... View more

White Papers

Diabetes in France

Diabetes in FranceJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Diabetes in Germany

Diabetes in GermanyJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Connected data and the use of smartphone…

Connected data and the use of smartphone enabled apps in market researchPaul Mannu

Rapid growth in smartphone usage offers healthcare researchers a useful tool to gain better understanding of how patients and healthcare professionals actually behave on a daily basis. Inaccuracies can arise... View info

Diabetes in the UK

Diabetes in the UKJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Further News & Articles

UK Prix Galien: New treatment for multidrug-resistant TB

This article is the latest in a series investigating some of the shortlisted products in the prestigious UK Prix ... Read more

Articles

Daiichi boosts cancer pipeline with $410m Ambit acquisition

Japan's Daiichi Sankyo has agreed a deal to buy Ambit Biosciences of the US for up to $410 million, bringing ... Read more

News

Play to learn? Gamification in healthcare

Are you ready to 'play to learn'? The latest trend in healthcare is to make this subject fun and hence more engaging... Read more

Articles

CHMP gives positive opinion for HIV drug Rezolsta

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a p... Read more

News

Probiodrug plans IPO to accelerate Alzheimer's ambitions

Germany's Probiodrug has become the latest European biotech to consider an initial public offering (IPO) as it t... Read more

News